Ajax-Loading

Company Selected - Astellas Pharma Inc. - Cashflow Statement















Ajax-Loading
Fiscal Year is From April To March - All Figures are in JPY, Thousands06/30/202503/31/202512/31/202409/30/2024View Chart

Hid Net Income

81,566,00050,747,000-57,427,00061,685,000

Hid Depreciation

196,668,000199,132,000200,092,000195,912,000

Hid Stock Based Compensation

- - - -

Hid Other Non-Cash Items

102,227,00092,191,000142,444,0001,154,000

Hid [-] Change In Working Capital

-137,234,000-142,095,000-116,005,000-55,468,000

HidHid Change Receivables

-118,740,000-104,735,000-119,835,000-93,809,000

HidHid Change To Inventory

-57,392,000-50,225,000-52,122,000-47,597,000

HidHid Change To Liabilities

- - - -

HidHid Change In Other Working Capital

- - - -

Hid Cash Flows Other Operating

- - - -

[-] Total Cash From Operating Activities

243,227,000199,975,000169,104,000203,283,000

Hid Capital Expenditures

-40,402,000-41,591,000-51,816,000-64,792,000

Hid Investments

- - -22,158,000.00-62,470,000.00

Hid Other Cashflows From Investing Activities

- - 19,924,000.0035,194,000.00

[-] Total Cashflows From Investing Activities

-73,293,000-94,882,000-112,300,000-120,681,000

Hid Net Borrowings

-25,954,000-75,949,000.00-32,833,000-159,993,000.00

Hid (+)Sale or (-)Purchase Of Stock

-730,000-6,960,000-6,960,000-6,961,000

Hid Dividends Paid

-132,475,000-128,993,000.00-128,993,000-125,509,000.00

Hid Other Cashflows From Financing Activities

43,819,00095,685,000.0083,499,000224,447,000.00

[-] Total Cashflows From Financing Activities

-260,490,000-261,367,000-139,626,000-122,355,000

Hid Begin Period CashFlow

188,372,000179,865,000292,993,000302,928,000

Hid Exchange Rate Changes

- - - -

Hid Change In Cash

27,027,0008,507,000-113,128,000-9,935,000

[-] End Period Cash Flow

215,399,000188,372,000179,865,000292,993,000

Free Cash Flow to the Firm (FCFF)

216,268,340171,420,254130,975,734151,194,332

Free Cash Flow to Equity (FCFE)

32,031,000-62,405,000.0032,766,000-73,191,000.00